| Dr Jonathan Louis Rall, DC | |
|
7390 Business Center Dr, Avon, IN 46123-8662 | |
| (317) 272-7000 | |
| (317) 272-4302 |
| Full Name | Dr Jonathan Louis Rall |
|---|---|
| Gender | Male |
| Speciality | Chiropractic |
| Experience | 6 Years |
| Location | 7390 Business Center Dr, Avon, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407320914 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | 08003076A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mohr Chiropractic Pc | 8022383439 | 3 |
News Archive
The role of mushrooms in reducing the risk of breast and prostate cancers and in stunting the growth of these cancers will be tested shortly with the start of human clinical trials at the City of Hope research centre in California.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented today at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden. The study met its primary endpoint with a 28 percent reduction in LDL-cholesterol, compared with an increase of 5 percent for placebo (p<0.001). The trial also met all of its secondary and tertiary endpoints.
› Verified 4 days ago
| Provider Name | Mohr Chiropractic Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1225564842 PECOS PAC ID: 8022383439 Enrollment ID: O20171011002742 |
News Archive
The role of mushrooms in reducing the risk of breast and prostate cancers and in stunting the growth of these cancers will be tested shortly with the start of human clinical trials at the City of Hope research centre in California.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented today at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden. The study met its primary endpoint with a 28 percent reduction in LDL-cholesterol, compared with an increase of 5 percent for placebo (p<0.001). The trial also met all of its secondary and tertiary endpoints.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan Louis Rall, DC 7390 Business Center Dr, Avon, IN 46123-8662 Ph: (317) 272-7000 | Dr Jonathan Louis Rall, DC 7390 Business Center Dr, Avon, IN 46123-8662 Ph: (317) 272-7000 |
News Archive
The role of mushrooms in reducing the risk of breast and prostate cancers and in stunting the growth of these cancers will be tested shortly with the start of human clinical trials at the City of Hope research centre in California.
Researchers have discovered an efficient and easy-to-use method for bonding together gels and biological tissues. A team headed by Ludwik Leibler, involving researchers from the Laboratoire Matière Molle et Chimie (CNRS/ESPCI ParisTech) and the Laboratoire Physico-Chimie des Polymères et Milieux Dispersés (CNRS/ UPMC/ESPCI ParisTech), has succeeded in obtaining very strong adhesion between two gels by spreading on their surface a solution containing nanoparticles.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
Genzyme Corp. and Isis Pharmaceuticals Inc. announced that data from the phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH) were presented today at the European Society of Cardiology's Congress 2010 in Stockholm, Sweden. The study met its primary endpoint with a 28 percent reduction in LDL-cholesterol, compared with an increase of 5 percent for placebo (p<0.001). The trial also met all of its secondary and tertiary endpoints.
› Verified 4 days ago
Mrs. Amanda Kay Wyant, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2279 Gray Birch Ct, Avon, IN 46123 Phone: 636-577-3464 | |
Cornerstone Chiropractic, P C Chiropractor Medicare: Medicare Enrolled Practice Location: 5250 E Us Highway 36, Suite 140, Avon, IN 46123 Phone: 317-745-7700 Fax: 317-745-1230 | |
Dr. James B Keating Iii, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 97 Dover St, Suite 500, Avon, IN 46123 Phone: 317-600-3070 Fax: 317-268-6361 | |
Spinalcare Physical Medicine Chiropractor Medicare: Medicare Enrolled Practice Location: 7030 E Us Highway 36, Avon, IN 46123 Phone: 317-272-4100 | |
Dr. John C Anderson, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 7390 Business Center Dr, Avon, IN 46123 Phone: 317-272-7000 Fax: 317-272-4302 | |
Dr. Justin David-gus Mohr, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 7390 Business Center Dr, Avon, IN 46123 Phone: 317-272-7000 Fax: 317-272-4302 | |
Mohr Chiropractic Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 7390 Business Center Dr, Avon, IN 46123 Phone: 317-272-7000 Fax: 317-272-4302 |